Marksans Pharma share price is Up ▲ 16% on 20-Sep-2024. | 28.5m shares traded.
Its CMP is Rs 318.35 and MCap is approx : 14408 Crores.
The stock is up ▲ 18.8% in 7 days,
up ▲ 44.3% in 1 month
and up ▲ 71.7% in 2 months.
Please click image for Latest Daily data.
Marksans Pharma results June 2024 (Standalone_YoY) Marksans Pharma revenue elevated to 255 crores up 40% in June 2024 quarter, compared with 182 crores in June 2023. Marksans Pharma Net profit is 32 crores down -27% in June 2024 quarter, compared with 44 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.
Click Image for Data | Scroll down for Comments
About Marksans Pharma :
Founded: 1992
Headquarters: India
Number of employees: 852 (2023)
Subsidiaries: Marksans Pharma Inc., Relonchem Limited…
Marksans Pharma Ltd is an Indian pharmaceutical company that manufactures prescription and over-the-counter drugs. The company was founded in 1992 and has four manufacturing facilities in India, the United Kingdom, and the United States. Marksans Pharma’s products are used in a variety of fields, including oncology, gastroenterology, antidiabetic, antibiotics, cardiovascular, pain management, and gynecology.
Marksans Pharma’s products include oral solid tablets, soft gelatin capsules, hard capsules, non-sterile liquids, ointments, and powder products.
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-
Please visit
To find any stock of Indian stock market, with every day % .
Only Data. Not Buy or Sell advice.
Please share to reach more people.